Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001725663-26-000003

Chief Financial Officer sold 16,477 shares at an average $13.01 ($214,379)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

WENTWORTH KORY JAMES · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-09 Sale : show line 1 in the form 10b5-1 −5,089 $13.00 $66,163 132,898 D
2026-03-10 Sale : show line 2 in the form 10b5-1 −11,388 $13.02 $148,216 121,510 D
Open-market sales · 16,477 sh · avg $13.01 · $214,379
Loading xslF345X05/wk-form4_1773261246.xml…